Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age.

Clinical trial NCT00871741 · TERMINATED

Trial details

NCT number: NCT00871741
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Tetanus Poliomyelitis Neisseria Meningitidis Haemophilus Influenzae Type b Diphtheria Acellular Pertussis Hepatitis B

Start date: 2009-04-01
Primary completion: 2009-06-25
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.